News und Analysen

Goldman Sachs's strategic analysts are forecasting a significant market transition for mid-February, despite current positive market momentum driven by the "January effect." The market's resilience

Home Depot's stock demonstrated remarkable momentum on Thursday, with shares climbing 1.7 percent to reach €402.30 on XETRA, building upon a strong opening of €401.15. The current trading price sits

Pfizer's stock experienced a modest decline of 0.8% to $26.24 in Thursday's New York trading session, yet the pharmaceutical giant's underlying performance tells a more compelling story. The company

Microsoft's stock demonstrated remarkable momentum on the NASDAQ, climbing 1.0 percent to reach $417.41 USD in afternoon trading. This upward trajectory reflects the company's impressive quarterly

Pharmaceutical giant Pfizer is embarking on a significant strategic shift with a heightened focus on artificial intelligence through a multi-year collaboration with technology firm Data4Cure. This

Home Depot's stock experienced a notable decline on Wednesday, dropping 1.0 percent to €392.50 on the Tradegate exchange, despite opening at €396.40. This movement comes against the backdrop of

UnitedHealth Group faced market turbulence on Tuesday as its shares dropped approximately 1.5% following serious allegations from a prominent hedge fund manager. The investor raised concerns about

IBM is set to make a significant move in the European market with a comprehensive euro-denominated bond offering totaling 3.5 billion euros. The technology giant plans to issue four different bond

Microsoft is expanding its industrial cloud solutions footprint through a groundbreaking collaboration with Aramco Digital and Armada. This strategic partnership aims to implement the world's first

Home Depot's stock has displayed notable volatility in recent trading sessions, reflecting a complex market sentiment towards the home improvement giant. After opening at €396.05, the stock

Boeing's stock demonstrated resilience on Tuesday in New York trading, maintaining stability around $175.91 amid encouraging developments from a key supplier. The trading session saw modest

Boeing's stock experienced further pressure on Monday, declining 0.9 percent to $174.92 USD in New York trading, as multiple challenges continue to plague the troubled aerospace manufacturer. The

Pfizer's recent breakthrough in cancer research is painting a promising picture for the pharmaceutical giant, despite its stock experiencing a slight dip of 0.9% to $26.27. The company has achieved

The recent leadership change at the U.S. Consumer Financial Protection Bureau (CFPB) has triggered a nuanced market response for Visa's stock, as investors carefully weigh the implications of

Microsoft has announced a significant modification to its service offerings, potentially impacting its stock market performance. The tech giant plans to discontinue its Virtual Private Network (VPN)

Coca-Cola's stock performance has entered a cautious phase, with shares experiencing a modest decline of 1.1 percent to $62.79, down from the opening price of $63.18. The current trading level

Boeing continues to face significant challenges as the aerospace giant marks its sixth consecutive year of losses, with its stock price reflecting the company's ongoing struggles. The shares have

Exxon Mobil's stock experienced significant gains at the start of the week, propelled by promising developments in its offshore operations. The energy giant has successfully expanded its strategic

Apple's recent performance has raised concerns among market analysts, despite posting impressive quarterly results with revenue of $124.3 billion and net profits climbing 7% to $36.3 billion. The

Visa has demonstrated remarkable financial performance in the first quarter of fiscal year 2024/25, with net profits rising 5% to reach $5.1 billion and revenue surging 10% to $9.5 billion. The

Walgreens Boots Alliance has made a historic shift in its corporate strategy by suspending its quarterly cash dividend after an unbroken 92-year streak of payments to shareholders. This dramatic

Intel's fourth-quarter 2023 performance presents a mixed picture, with revenue reaching $14.3 billion. While this figure represents a 7% year-over-year decline, it surpassed analyst expectations